IS6360A - Lyf til meðhöndlunar á lifrarbólgu C - Google Patents

Lyf til meðhöndlunar á lifrarbólgu C

Info

Publication number
IS6360A
IS6360A IS6360A IS6360A IS6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A
Authority
IS
Iceland
Prior art keywords
hepatitis
medicines
treatment
Prior art date
Application number
IS6360A
Other languages
English (en)
Icelandic (is)
Inventor
Nowicky Wassyl
Original Assignee
Nowicky Wassyl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassyl filed Critical Nowicky Wassyl
Publication of IS6360A publication Critical patent/IS6360A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS6360A 2000-03-22 2002-04-24 Lyf til meðhöndlunar á lifrarbólgu C IS6360A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain

Publications (1)

Publication Number Publication Date
IS6360A true IS6360A (is) 2002-04-24

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6360A IS6360A (is) 2000-03-22 2002-04-24 Lyf til meðhöndlunar á lifrarbólgu C

Country Status (17)

Country Link
JP (1) JP2003527414A (zh)
KR (1) KR20020087045A (zh)
CN (1) CN1416347A (zh)
AT (1) AT408719B (zh)
AU (1) AU2001239000A1 (zh)
BG (1) BG107088A (zh)
BR (1) BR0107211A (zh)
CA (1) CA2389173A1 (zh)
EA (1) EA200200584A1 (zh)
HR (1) HRP20020367A2 (zh)
IL (1) IL149314A0 (zh)
IS (1) IS6360A (zh)
MA (1) MA25509A1 (zh)
MX (1) MXPA02004993A (zh)
NO (1) NO20022253D0 (zh)
PL (1) PL365000A1 (zh)
WO (1) WO2001070203A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2008039179A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
BR0107211A (pt) 2004-01-06
ATA4812000A (de) 2001-07-15
WO2001070203A2 (de) 2001-09-27
EA200200584A1 (ru) 2003-06-26
MXPA02004993A (es) 2003-10-14
JP2003527414A (ja) 2003-09-16
CA2389173A1 (en) 2001-09-27
PL365000A1 (en) 2004-12-27
KR20020087045A (ko) 2002-11-21
BG107088A (en) 2003-05-30
IL149314A0 (en) 2002-11-10
AU2001239000A1 (en) 2001-10-03
CN1416347A (zh) 2003-05-07
HRP20020367A2 (en) 2004-02-29
NO20022253L (no) 2002-05-10
WO2001070203A3 (de) 2002-09-06
NO20022253D0 (no) 2002-05-10
AT408719B (de) 2002-02-25
MA25509A1 (fr) 2002-07-01

Similar Documents

Publication Publication Date Title
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
IS6286A (is) Efnasambönd til meðhöndlunar á blóðþurrð
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
IS7929A (is) Lyf á föstu formi til inntöku um munn
NL1015859A1 (nl) Farmaceutische preparaten.
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
IS2711B3 (is) Aðferð til framleiðslu á amín platínu komplexum
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20014490D0 (no) Medisinske blandinger
DE60132600D1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
ATE265852T1 (de) Geschmackskaschierte flüssige arzneizubereitungen
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
MXPA03001425A (es) Compuestos farmaceuticos.
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20013958L (no) Legemiddel for behandling av höyt blodtrykk
NO20005179D0 (no) Medikament behandling
FI19991925A (fi) Levosimendaanin farmaseuttisia liuoksia
IS5600A (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
BR0000687B1 (pt) peÇa Íntima descartÁvel.
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte